Renal Cell Carcinoma

Part I. Introduction. The Epidemiology of Renal Cell Carcinoma, Joshua E. Muscat. The Pathology of Renal Neoplasms, Howard S. Levin and Jonathan L. Myles. Immunologic Response to Renal Cell Carcinoma, James H. Finke, Lisa Salvucci Kierstead, Elena Ranieri, and Walter J. Storkus. Molecular Mechanisms of Immune Dysfunction in Renal Cell Carcinoma, Robert G. Uzzo, Patricia Rayman, Andrew C. Novick, Ronald M. Bukowski, and James H. Finke. Molecular Genetics of Renal Cell Carcinoma, Erik Enquist, Norman Zambrano, Burton Zbar, W. Marston Linehan, and McClellan M. Walther. Screening for Renal Cell Carcinoma, Evan B. Cohn and Steven C. Campbell. Renal Cell Carcinoma: Diagnosis and Staging, Joel W. Slaton and David A. Swanson. Paraneoplastic Syndromes in Renal Cell Carcinoma, Riyadh Aldaabil and David Peereboom. Prognostic Factors in Metastatic Renal Cell Carcinoma, Paul J. Elson. Part II. Management of Localized Renal Cell Carcinoma. Radical Nephrectomy and Nephron-Sparing Surgery for Localized Renal Cell Carcinoma, Andrew C. Novick. Management of Patients with Renal Cell Carcinoma and Vena Caval Thrombi, Chad W. M. Ritenour and Fray F. Marshall. Laparoscopic Surgery for Renal Cell Carcinoma, Inderbir S. Gill. Adjuvant Therapy for Renal Cell Carcinoma, Ronald M. Bukowski. Part III. Management of Advanced and/or Metastatic Renal Cell Carcinoma. The Role of Nephrectomy and Metastasectomy for Advanced Renal Cell Carcinoma, Robert G. Uzzo and Andrew C. Novick. Management of Pulmonary Metastases in Renal Cell Carcinoma Patients, Thomas W. Rice. Management of Skeletal Metastases in Renal Cell Carcinoma Patients, Michael J. Joyce. Management of Central Nervous System Metastases in Renal Cell Carcinoma Patients, John H. Suh and Gene H. Barnett. Chemotherapy for Metastatic Renal Cell Carcinoma (RCC), Javier A. Ruiz, Haralambos Raftopoulos, and Daniel P. Petrylak. Interleukin-2 in Metastatic Renal Cell Carcinoma, Thomas Olencki and Ronald M. Bukowski. Role of Interferon in Metastatic Renal Cell Carcinoma, Robert J. Motzer and William J. Berg. Combination Therapy for Treatment of Advanced Renal Cell Carcinoma, Jens Atzpodien, J. Janssen, J. Buer, S. Sel, and K. Oevermann. Monoclonal Antibodies in Advanced Renal Cell Carcinoma, Egbert Oosterwijk, Chaitanya R. Divgi, Martijn S. Steffens, and Neil H. Bander. Adoptive Immunotherapy in Renal Cell Carcinoma, Barbara J. Gitlitz, Arie S. Belldegrun, and Robert A. Figlin. Antiangiogenic Agents and Strategies in Renal Cell Carcinoma, Kevin R. Bigelow, Michael T. Spiotto, and Walter M. Stadler. Therapy for Patients with Uncommon Histologic Varieties of Renal Cell Carcinoma, Robert J. Amato. Palliation in Patients with Advanced Renal Cell Carcinoma: The Interface with Antineoplastic Therapy, Donna S. Zhukovsky. Index.